Privacy Act of 1974 Report of an Altered System of Records, 23869-23872 [E9-11946]
Download as PDF
dwashington3 on PROD1PC60 with NOTICES
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
MSC 7814, Bethesda, MD 20892, 301–594–
1321, diramig@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Review of
Competing Revisions.
Date: June 5, 2009.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street, NW.,
Washington, DC 20037.
Contact Person: Elisabeth Koss, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 435–
1721, kosse@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Competitive
Revisions; Neurotechnology.
Date: June 5, 2009.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Melrose Hotel, 2430 Pennsylvania
Avenue, NW., Washington, DC 20037.
Contact Person: Robert C. Elliott, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3130,
MSC 7850, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Molecular
Obesity and Diabetes ARRA CR.
Date: June 5, 2009.
Time: 10:45 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites New Orleans—
Convention Center, 315 Julia Street, New
Orleans, LA 70130.
Contact Person: Ann A. Jerkins, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6154,
MSC 7892, Bethesda, MD 20892, 301–435–
4514, jerkinsa@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Bioengineering Competitive Revisions.
Date: June 5, 2009.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Dulles Airport Hotel,
2200 Centreville Road, Herndon, VA 20170.
Contact Person: Marc Rigas, PhD, Scientific
Review Officer, Center for Scientific Review,
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
National Institutes of Health, 6701 Rockledge
Drive, Room 5158, MSC 7849, Bethesda, MD
20892, 301–402–1074, rigasm@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Psychosocial Risk Prevention: ARRA
Revision Applications.
Date: June 5, 2009.
Time: 12 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Avenue Hotel Chicago, 160 Huron
Street, Chicago, IL 60611.
Contact Person: Anna L. Riley, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7759, Bethesda, MD 20892, 301–435–
2889, rileyann@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Anti-Microbial and Resistance.
Date: June 5, 2009.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Guangyong Ji, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3211,
MSC 7808, Bethesda, MD 20892, 301–435–
1146, jig@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 13 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11827 Filed 5–20–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
23869
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Special
Grants Review Committee.
Date: June 2–3, 2009.
Time: 7 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Helen Lin, PhD, Scientific
Review Administrator, NIH/NIAMS/RB, 6701
Democracy Blvd., Suite 800, Plaza One,
Bethesda, MD 20817, 301–594–4952,
linh1@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
Dated: May 14, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11828 Filed 5–20–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Privacy Act of 1974 Report of an
Altered System of Records
AGENCY: Health Resources and Services
Administration (HRSA), HHS.
ACTION: Notice of an altered system of
records.
SUMMARY: In accordance with the
requirements of the Privacy Act of 1974,
the Health Resources and Services
Administration (HRSA) is publishing
notice of a proposal to alter the system
of records for the C.W. Bill Young Cell
Transplantation Program. This system of
records is required to comply with the
implementation directives of Public
Law 109–129. Records are used for the
C.W. Bill Young Cell Transplantation
Program’s planning, implementation,
evaluation, monitoring, and document
storage purposes.
The purposes of these alterations are
to update the locations of this system,
E:\FR\FM\21MYN1.SGM
21MYN1
dwashington3 on PROD1PC60 with NOTICES
23870
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
to clarify that existing routine use
number 4 for this system includes
disclosures to subcontractors, and to
add routine use number 9 related to
notification of breaches in security or
confidentiality of records maintained in
the system.
DATES: Persons wishing to comment on
this revised system of records notice
may do so until June 30, 2009. Unless
there is a further notice in the Federal
Register, this revised system of records
will become effective on June 30, 2009.
ADDRESSES: Please address comments to
Director, Blood Stem Cell
Transplantation Program, HRSA/HSB/
DoT, 5600 Fishers Lane, Room 12C–06,
Rockville, Maryland 20857; telephone
(301) 443–7577. This is not a toll-free
number. Comments received will be
available for inspection at this same
address from 9 a.m. to 3 p.m., Monday
through Friday.
FOR FURTHER INFORMATION CONTACT:
Director, Blood Stem Cell
Transplantation Program, HRSA/HSB/
DoT, 5600 Fishers Lane, Room 12C–06,
Rockville, Maryland 20857; telephone
(301) 443–7577; fax (301) 594–6095.
These are not toll-free numbers.
SUPPLEMENTARY INFORMATION: The
Health Resources and Services
Administration published in the
Federal Register of August 17, 2007,
notice of a new system of records, 09–
15–0068, C.W. Bill Young Cell
Transplantation Program. The Stem Cell
Therapeutic and Research Act of 2005
(the Act) establishes the C.W. Bill
Young Cell Transplantation Program
(the Program), which maintains
information related to patients in need
of a blood stem cell transplant and
potential adult volunteer blood stem
cell donors who have agreed to be listed
on the registry maintained by the
Program. Additionally, the Program
maintains information related to the
outcomes of patients who have
undergone blood stem cell
transplantation.
The Stem Cell Therapeutic and
Research Act of 2005 authorizes the
C.W. Bill Young Cell Transplantation
Program and provides for the collection,
maintenance, and distribution of human
blood stem cells for the treatment of
patients and for research. The Program
consists of four interrelated components
each operated under a separate contract.
The four components are: The Bone
Marrow Coordinating Center; the Cord
Blood Coordinating Center; the Office of
Patient Advocacy/Single Point of
Access; and the Stem Cell Therapeutic
Outcomes Database. The contracts for
operation of the Bone Marrow
Coordinating Center, Cord Blood
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
Coordinating Center, and Office of
Patient Advocacy/Single Point of Access
were awarded to the National Marrow
Donor Program in September, 2006. A
single contract for the Stem Cell
Therapeutic Outcomes Database was
awarded to the Center for International
Blood and Marrow Transplant Research
(CIBMTR) at the Medical College of
Wisconsin in September 2006 as well.
As identified by the Act, the Program
is charged with: Operating a system for
identifying, matching, and facilitating
the distribution of bone marrow that is
suitably matched to candidate patients;
operating a system for identifying,
matching, and facilitating the
distribution of donated umbilical cord
blood units that are suitably matched to
candidate patients; providing a means
by which transplant physicians, other
healthcare professionals, and patients
can electronically search for and access
all available adult marrow donors
available through the Program;
recruiting potential adult volunteer
marrow donors; coordinating with other
Federal programs to maintain and
expand medical contingency response
capabilities; carrying out informational
and educational activities; providing
patient advocacy services; providing
case management services for potential
donors; and collecting, analyzing, and
publishing blood stem cell
transplantation related data, including
patient outcomes data, in a standardized
electronic format. This system of
records is required to comply with the
implementation directives of the Act,
Public Law 109–129. The records will
be used for the C.W. Bill Young Cell
Transplantation Program’s planning,
implementation, evaluation, monitoring,
and document storage purposes.
Mary K. Wakefield,
Administrator.
SYSTEM NUMBER:
09–15–0068.
SYSTEM NAME:
C.W. Bill Young Cell Transplantation
Program.
SECURITY CLASSIFICATION:
None.
SYSTEM LOCATION:
Data collected by the C.W. Bill Young
Cell Transplantation Program (the
Program) are maintained by the National
Marrow Donor Program (NMDP) and the
Medical College of Wisconsin,
contractors for the Program. The
Division of Transplantation within the
Health Resources and Services
Administration oversees the Program
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
and the contracts with the NMDP and
Medical College of Wisconsin.
Records associated with the C.W. Bill
Young Cell Transplantation Program are
located at the National Marrow Donor
Program, 3001 Broadway Street, NE.,
Suite 500, Minneapolis, MN 55413 and
Time Warner Telecom, 5488 Feltl Road,
Minnetonka, MN 55343.
Additional records associated with
the Stem Cell Therapeutic Outcomes
Database component of the Program are
located at the Medical College of
Wisconsin’s Center for International
Blood and Marrow Transplant Research
(CIBMTR), 9200 W. Wisconsin Avenue,
Milwaukee, WI 53226.
CATEGORIES OF INDIVIDUALS COVERED BY THE
SYSTEM:
1. Volunteers whose bone marrow,
peripheral blood or cord blood
donations are to be used for
hematopoietic reconstitution or other
therapeutic applications on behalf of
patients in need.
2. Patients searching for an unrelated
donor or who are receiving transplant or
ancillary services through the C.W. Bill
Young Cell Transplantation Program.
3. Recipients of allogeneic blood stem
cell transplantation.
CATEGORIES OF RECORDS IN THE SYSTEM:
Records consist of documents (printed
and electronic) containing all
information necessary to manage and
facilitate patient searches and to track
detailed post-transplant clinical status,
including documentation and
correspondence concerning patients in
need of (or recipients of) blood stem cell
transplants and volunteers listed on the
Program’s registry as potential blood
stem cell donors. These documents
include all information necessary to
manage and facilitate patient searches,
and to track detailed post-transplant and
post-donation clinical status. The
following information is maintained in
the system: Individual identifiers about
the recipients and donors (e.g., social
security number (voluntary), names,
date of birth, etc.); recipient and donor
demographics and socio-demographics;
recipients’ disease, disease history and
treatment, transplant procedure details,
post-transplantation medical history,
events, and complications; donor
medical history; donation procedure
and blood stem cell product details;
long-term follow-up of medical
outcomes and assessment of functioning
for donors and recipients; provider
identifiers; transplant and collection
facility identifiers; and donor
management center identifiers.
E:\FR\FM\21MYN1.SGM
21MYN1
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
AUTHORITY FOR MAINTENANCE OF THE SYSTEM:
Public Law 109–129 establishes the
C.W. Bill Young Cell Transplantation
Program, authorizing the Department to
establish by contract a system for
identifying, matching, and facilitating
bone marrow and cord blood
transplants, including recruitment,
patient advocacy and maintenance of a
stem cell therapeutic outcomes
database.
dwashington3 on PROD1PC60 with NOTICES
PURPOSE(S):
The C.W. Bill Young Cell
Transplantation Program is comprised
of the Office of Patient Advocacy/Single
Point of Access, the Bone Marrow
Coordinating Center, the Cord Blood
Coordinating Center, and the Stem Cell
Therapeutic Outcomes Database. The
purpose of the system is to support the
Program’s mission to facilitate and
increase access to blood stem cell
transplantation. Additionally,
information in the system will be used
to advise the Secretary of the
Department of Health and Human
Services and the Advisory Council on
Blood Stem Cell Transplantation on
matters related to the Program and for
ongoing monitoring of the Program by
the Health Resources and Services
Administration to determine the
effectiveness of the Program and to
guide implementation of the policies
and procedures that govern the
Program’s structure. Records from this
system will be used to carry out the
statutory charge of the C.W. Bill Young
Cell Transplantation Program.
Specifically, records vital and attendant
to the full scope of activities involved at
every stage of the process of facilitation
of blood stem cell transplantation or
other therapies for recipients suitably
matched to biologically unrelated
donors; analyzing factors affecting
transplant outcomes; monitoring and
reporting of adverse events; monitoring
and reporting of quality, compliance,
and performance indicators; monitoring
and reporting on the size and
composition of the registry of adult bone
marrow donors and size and
composition of the umbilical cord blood
inventory; and to provide pertinent
information to transplant programs,
physicians, patients, other entities
awarded a contract under Section 379 of
the Public Health Service Act, donor
registries, and cord blood banks as
stated in Public Law 109–129.
ROUTINE USES OF RECORDS MAINTAINED IN THE
SYSTEM, INCLUDING CATEGORIES OF USERS AND
THE PURPOSES OF SUCH USES:
Disclosure of records from this system
of records may be made as provided in
the Privacy Act, 5 U.S.C. 552a(b), and to
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
the following recipients for the purposes
stated:
1. Departmental contractors who have
been engaged by the Department to
assist in accomplishment of a
departmental function related to the
purposes of this system of records and
who have a need to access the records
in order to carry out that function.
2. Transplant centers, physicians and
staff, and NMDP participating
organizations, for the purpose of
searching for donors or products and/or
facilitating transplants, matching donor
blood stem cells with recipients,
monitoring participant outcomes, and
monitoring compliance of member
organizations with contractor
requirements.
3. Personnel involved in the care of
volunteer blood stem cell donors and
management of their participation in the
Program. Disclosures of clinically
relevant de-identified information
contained in certain donor records may
be made to transplant physicians,
patients or their designated
representatives for purposes of
facilitating searches for blood stem cell
donors or products and/or facilitation of
unrelated donor transplants.
4. Disclosures may be made by the
contractors for the Office of Patient
Advocacy/Single Point of Access, the
Bone Marrow Coordinating Center, the
Cord Blood Coordinating Center, the
Stem Cell Therapeutic Outcomes
Database, NMDP and CIBMTR
participating centers to one another and
their subcontractors (so long as such
subcontractors are contractually bound
to comply with the Privacy Act) as well
as participating umbilical cord blood
banks to carry out the purposes of the
C.W. Bill Young Cell Transplantation
Program.
5. Disclosure may be made to the
Department of Justice when: (a) The
agency or any component thereof; or (b)
any employee of the agency in his or her
official capacity; (c) any employee of the
agency in his or her individual capacity
where agency or the Department of
Justice has agreed to represent the
employee; or (d) the United States
Government, is a party to litigation or
has an interest in such litigation, and by
careful review, the agency determines
that the records are both relevant and
necessary to the litigation and the use of
such records by the Department of
Justice is therefore deemed by the
agency to be for a purpose that is
compatible with the purpose for which
the agency collected the records.
6. Disclosure may be made to a court
or adjudicative body in a proceeding
when: (a) The agency or any component
thereof; or (b) any employee of the
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
23871
agency in his or her official capacity; (c)
any employee of the agency in his or her
individual capacity where agency or the
Department of Justice has agreed to
represent the employee; or (d) the
United States Government, is a party to
litigation or has an interest in such
litigation, and by careful review, the
agency determines that the records are
both relevant and necessary to the
litigation and the use of such records is
therefore deemed by the agency to be for
a purpose that is compatible with the
purpose for which the agency collected
the records.
7. Disclosure may be made to a
congressional office from the record of
an individual in response to a verified
inquiry from the congressional office
made at the written request of that
individual.
8. Disclosure may be made for
research purposes. Rarely, with the
appropriate safeguards and consistent
with the applicable provisions of the
Privacy Act and the Common Rule (45
CFR Part 46), disclosure for research
purposes may be made when the
Department, independently or through
its contractor(s): (a) Has determined that
the use or disclosure does not violate
legal or policy limitations under which
the record was provided, collected, or
obtained; (b) has determined that a bona
fide research/analysis purpose exists; (c)
has required the recipient to: (1)
Establish strict limitations concerning
the receipt and use of patient-identified
data; (2) establish reasonable
administrative, technical, and physical
safeguards to protect the confidentiality
of the data and to prevent the
unauthorized use or disclosure of the
record; (3) remove, destroy, or return the
information that identifies the
individual at the earliest time at which
removal or destruction can be
accomplished consistent with the
purpose of the research project, unless
the recipient has presented adequate
justification of a research or health
nature for retaining such information;
and (4) make no further use or
disclosure of the record except as
authorized by HHS or its contractor(s) or
when required by law; (d) has
determined that other applicable
safeguards or protocols will be followed;
and (e) has secured a written statement
attesting to the recipient’s
understanding of, and willingness to
abide by these provisions.
9. To appropriate Federal agencies
and Department contractors that have a
need to know the information for the
purpose of assisting the Department’s
efforts to respond to a suspected or
confirmed breach of the security or
confidentiality of information
E:\FR\FM\21MYN1.SGM
21MYN1
23872
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
maintained in this system of records,
and the information disclosed is
relevant and necessary for that
assistance.
POLICIES AND PRACTICES FOR STORING,
RETRIEVING, ACCESSING, RETAINING, AND
DISPOSING OF RECORDS IN THE SYSTEM:
STORAGE:
Records are maintained in file folders
and in computer data files.
RETRIEVABILITY:
Patient and donor records may be
retrieved by a unique ID assigned by the
system or through the use of other
identifying information (e.g., names,
date of birth, Social Security Number, or
address).
dwashington3 on PROD1PC60 with NOTICES
SAFEGUARDS:
1. Authorized users: Access is limited
to authorized personnel responsible for
administering the program, including
program managers and program
specialists who have responsibilities for
implementing the program and the
HRSA Information Systems Security
Officer. The contractor(s) shall maintain
current lists of authorized users.
Retrieval of donor or patient records
will be limited to authorized users for
search, outcomes data collection and
data auditing, or transplant management
purposes.
2. Assign Responsibility for Security:
Responsibility is assigned to a
management official knowledgeable of
the nature of the information and
processes supported by the C.W. Bill
Young Cell Transplantation Program
and in the management, personnel,
operational, and technical controls used
to protect it.
3. Perform Risk Assessment: A risk
assessment was conducted in
conjunction with the development of
the system. The system design ensures
vulnerabilities, risks, and other security
concerns are identified and addressed in
the system design and throughout the
life cycle of the project. This is
consistent with the HHS Automated
Information Systems Security Program
Handbook.
4. Certification and Accreditation:
The Program’s electronic data systems
are certified under the auspices of
HRSA’s Office of Information
Technology Certification and
Accreditation system.
5. Physical safeguards: All computer
equipment and files and hard copy files
are stored in areas where fire and life
safety codes (e.g., OSHA standards) are
strictly enforced. All automated and
non-automated documents are protected
on a 24-hour basis. Perimeter security
includes intrusion alarms, key/
passcard/combination controls, and
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
receptionist controlled area. Most hard
copy files are maintained in a file room
used solely for purposes of the Program
with access limited by combination lock
to authorized users identified above.
Computer files are password protected
and are accessible only by use of
computers which are password
protected. Servers are password
protected and protected in locked
rooms, with access restricted to specific
authorized staff using controls specified
in the certification and accreditation
process.
6. Procedural safeguards: A password
is required to access computer files. All
users of personal information in
connection with the performance of
their jobs protect information from
public view and from unauthorized
personnel entering an unsupervised
area. All authorized users sign a
nondisclosure statement. All passwords,
keys and/or combinations are changed
when a person leaves or no longer has
authorized duties. Access to records is
limited to those authorized personnel
trained in accordance with the Privacy
Act and automated data processing
(ADP) security procedures. The
transmission of records is protected
using secure protocols. Individuals with
access to the system have User IDs and
passwords and must be granted access
to the system. External access to the
data requires two-factor authentication.
The safeguards described above were
established in accordance with NIST
800–53 and OMB Circular A–130
Appendix III.
RETENTION AND DISPOSAL:
HRSA is working with the National
Archives and Records Administration
(NARA) to obtain the appropriate
retention value of these records.
SYSTEM MANAGER AND ADDRESS:
Director, Blood Stem Cell
Transplantation Program, HRSA,
Parklawn Building, Room 12C–06, 5600
Fishers Lane, Rockville, MD 20857.
NOTIFICATION PROCEDURE:
Requests must be made to the System
Manager.
Requests by mail: Requests for
information and/or access to records
received by mail must contain
information providing the identity of
the writer, and a reasonable description
of the record desired, and whom it
concerns. Written requests must contain
the name and address of the requester,
his/her date of birth and his/her
signature. Requests must be notarized to
verify the identity of the requester, or
the requester must certify that (s)he is
the individual who (s)he claims to be
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
and that (s)he understands that to
knowingly and willfully request or
acquire a record pertaining to another
individual under false pretenses is a
criminal offense under the Privacy Act
subject to a $5,000 fine (45 CFR
5b.5(b)(2)(ii)).
Requests in person or by telephone,
electronic mail or facsimile cannot be
honored.
REQUESTS IN PERSON:
No requests in person at the system
location will be honored.
REQUESTS BY TELEPHONE:
Since positive identification of the
caller cannot be established, telephone
requests are not honored.
RECORD ACCESS PROCEDURES:
Record access procedures are the
same as notification procedures.
Requesters should also provide a
reasonable description of the contents of
the record being sought. A parent or
guardian who requests notification of, or
access to, a minor’s/incompetent
person’s record shall designate a family
physician or other health professional
(other than a family member) to whom
the record, if any, will be sent. The
parent or guardian must verify
relationship to the minor/incompetent
person as well as his/her own identity.
Records will be mailed only to the
requester’s address that is on file, unless
a different address is demonstrated by
official documentation.
CONTESTING RECORD PROCEDURES:
To contest a record in the system,
contact the official at the address
specified above and reasonably identify
the record, specify the information
being contested, and state the corrective
action sought and the reason(s) for
requesting the correction, along with
supporting documentation to show how
the record is inaccurate, incomplete,
untimely, or irrelevant.
RECORD SOURCE CATEGORIES:
Sources of records include, but are
not limited to, patients, donors, and/or
their representatives under the C.W. Bill
Young Cell Transplantation Program
and any other sources of information or
documentation submitted by any other
person or entity for inclusion in a
request for the purpose of facilitating
and monitoring blood stem cell
transplantation (e.g., transplant center
healthcare professionals).
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS
OF THE ACT:
None.
[FR Doc. E9–11946 Filed 5–20–09; 8:45 am]
BILLING CODE 4165–15–P
E:\FR\FM\21MYN1.SGM
21MYN1
Agencies
[Federal Register Volume 74, Number 97 (Thursday, May 21, 2009)]
[Notices]
[Pages 23869-23872]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11946]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Privacy Act of 1974 Report of an Altered System of Records
AGENCY: Health Resources and Services Administration (HRSA), HHS.
ACTION: Notice of an altered system of records.
-----------------------------------------------------------------------
SUMMARY: In accordance with the requirements of the Privacy Act of
1974, the Health Resources and Services Administration (HRSA) is
publishing notice of a proposal to alter the system of records for the
C.W. Bill Young Cell Transplantation Program. This system of records is
required to comply with the implementation directives of Public Law
109-129. Records are used for the C.W. Bill Young Cell Transplantation
Program's planning, implementation, evaluation, monitoring, and
document storage purposes.
The purposes of these alterations are to update the locations of
this system,
[[Page 23870]]
to clarify that existing routine use number 4 for this system includes
disclosures to subcontractors, and to add routine use number 9 related
to notification of breaches in security or confidentiality of records
maintained in the system.
DATES: Persons wishing to comment on this revised system of records
notice may do so until June 30, 2009. Unless there is a further notice
in the Federal Register, this revised system of records will become
effective on June 30, 2009.
ADDRESSES: Please address comments to Director, Blood Stem Cell
Transplantation Program, HRSA/HSB/DoT, 5600 Fishers Lane, Room 12C-06,
Rockville, Maryland 20857; telephone (301) 443-7577. This is not a
toll-free number. Comments received will be available for inspection at
this same address from 9 a.m. to 3 p.m., Monday through Friday.
FOR FURTHER INFORMATION CONTACT: Director, Blood Stem Cell
Transplantation Program, HRSA/HSB/DoT, 5600 Fishers Lane, Room 12C-06,
Rockville, Maryland 20857; telephone (301) 443-7577; fax (301) 594-
6095. These are not toll-free numbers.
SUPPLEMENTARY INFORMATION: The Health Resources and Services
Administration published in the Federal Register of August 17, 2007,
notice of a new system of records, 09-15-0068, C.W. Bill Young Cell
Transplantation Program. The Stem Cell Therapeutic and Research Act of
2005 (the Act) establishes the C.W. Bill Young Cell Transplantation
Program (the Program), which maintains information related to patients
in need of a blood stem cell transplant and potential adult volunteer
blood stem cell donors who have agreed to be listed on the registry
maintained by the Program. Additionally, the Program maintains
information related to the outcomes of patients who have undergone
blood stem cell transplantation.
The Stem Cell Therapeutic and Research Act of 2005 authorizes the
C.W. Bill Young Cell Transplantation Program and provides for the
collection, maintenance, and distribution of human blood stem cells for
the treatment of patients and for research. The Program consists of
four interrelated components each operated under a separate contract.
The four components are: The Bone Marrow Coordinating Center; the Cord
Blood Coordinating Center; the Office of Patient Advocacy/Single Point
of Access; and the Stem Cell Therapeutic Outcomes Database. The
contracts for operation of the Bone Marrow Coordinating Center, Cord
Blood Coordinating Center, and Office of Patient Advocacy/Single Point
of Access were awarded to the National Marrow Donor Program in
September, 2006. A single contract for the Stem Cell Therapeutic
Outcomes Database was awarded to the Center for International Blood and
Marrow Transplant Research (CIBMTR) at the Medical College of Wisconsin
in September 2006 as well.
As identified by the Act, the Program is charged with: Operating a
system for identifying, matching, and facilitating the distribution of
bone marrow that is suitably matched to candidate patients; operating a
system for identifying, matching, and facilitating the distribution of
donated umbilical cord blood units that are suitably matched to
candidate patients; providing a means by which transplant physicians,
other healthcare professionals, and patients can electronically search
for and access all available adult marrow donors available through the
Program; recruiting potential adult volunteer marrow donors;
coordinating with other Federal programs to maintain and expand medical
contingency response capabilities; carrying out informational and
educational activities; providing patient advocacy services; providing
case management services for potential donors; and collecting,
analyzing, and publishing blood stem cell transplantation related data,
including patient outcomes data, in a standardized electronic format.
This system of records is required to comply with the implementation
directives of the Act, Public Law 109-129. The records will be used for
the C.W. Bill Young Cell Transplantation Program's planning,
implementation, evaluation, monitoring, and document storage purposes.
Mary K. Wakefield,
Administrator.
System Number:
09-15-0068.
System Name:
C.W. Bill Young Cell Transplantation Program.
Security Classification:
None.
System Location:
Data collected by the C.W. Bill Young Cell Transplantation Program
(the Program) are maintained by the National Marrow Donor Program
(NMDP) and the Medical College of Wisconsin, contractors for the
Program. The Division of Transplantation within the Health Resources
and Services Administration oversees the Program and the contracts with
the NMDP and Medical College of Wisconsin.
Records associated with the C.W. Bill Young Cell Transplantation
Program are located at the National Marrow Donor Program, 3001 Broadway
Street, NE., Suite 500, Minneapolis, MN 55413 and Time Warner Telecom,
5488 Feltl Road, Minnetonka, MN 55343.
Additional records associated with the Stem Cell Therapeutic
Outcomes Database component of the Program are located at the Medical
College of Wisconsin's Center for International Blood and Marrow
Transplant Research (CIBMTR), 9200 W. Wisconsin Avenue, Milwaukee, WI
53226.
Categories of Individuals Covered by the System:
1. Volunteers whose bone marrow, peripheral blood or cord blood
donations are to be used for hematopoietic reconstitution or other
therapeutic applications on behalf of patients in need.
2. Patients searching for an unrelated donor or who are receiving
transplant or ancillary services through the C.W. Bill Young Cell
Transplantation Program.
3. Recipients of allogeneic blood stem cell transplantation.
Categories of Records in the System:
Records consist of documents (printed and electronic) containing
all information necessary to manage and facilitate patient searches and
to track detailed post-transplant clinical status, including
documentation and correspondence concerning patients in need of (or
recipients of) blood stem cell transplants and volunteers listed on the
Program's registry as potential blood stem cell donors. These documents
include all information necessary to manage and facilitate patient
searches, and to track detailed post-transplant and post-donation
clinical status. The following information is maintained in the system:
Individual identifiers about the recipients and donors (e.g., social
security number (voluntary), names, date of birth, etc.); recipient and
donor demographics and socio-demographics; recipients' disease, disease
history and treatment, transplant procedure details, post-
transplantation medical history, events, and complications; donor
medical history; donation procedure and blood stem cell product
details; long-term follow-up of medical outcomes and assessment of
functioning for donors and recipients; provider identifiers; transplant
and collection facility identifiers; and donor management center
identifiers.
[[Page 23871]]
Authority for Maintenance of The System:
Public Law 109-129 establishes the C.W. Bill Young Cell
Transplantation Program, authorizing the Department to establish by
contract a system for identifying, matching, and facilitating bone
marrow and cord blood transplants, including recruitment, patient
advocacy and maintenance of a stem cell therapeutic outcomes database.
Purpose(s):
The C.W. Bill Young Cell Transplantation Program is comprised of
the Office of Patient Advocacy/Single Point of Access, the Bone Marrow
Coordinating Center, the Cord Blood Coordinating Center, and the Stem
Cell Therapeutic Outcomes Database. The purpose of the system is to
support the Program's mission to facilitate and increase access to
blood stem cell transplantation. Additionally, information in the
system will be used to advise the Secretary of the Department of Health
and Human Services and the Advisory Council on Blood Stem Cell
Transplantation on matters related to the Program and for ongoing
monitoring of the Program by the Health Resources and Services
Administration to determine the effectiveness of the Program and to
guide implementation of the policies and procedures that govern the
Program's structure. Records from this system will be used to carry out
the statutory charge of the C.W. Bill Young Cell Transplantation
Program. Specifically, records vital and attendant to the full scope of
activities involved at every stage of the process of facilitation of
blood stem cell transplantation or other therapies for recipients
suitably matched to biologically unrelated donors; analyzing factors
affecting transplant outcomes; monitoring and reporting of adverse
events; monitoring and reporting of quality, compliance, and
performance indicators; monitoring and reporting on the size and
composition of the registry of adult bone marrow donors and size and
composition of the umbilical cord blood inventory; and to provide
pertinent information to transplant programs, physicians, patients,
other entities awarded a contract under Section 379 of the Public
Health Service Act, donor registries, and cord blood banks as stated in
Public Law 109-129.
Routine Uses of Records Maintained In the System, Including Categories
of Users and the Purposes of Such Uses:
Disclosure of records from this system of records may be made as
provided in the Privacy Act, 5 U.S.C. 552a(b), and to the following
recipients for the purposes stated:
1. Departmental contractors who have been engaged by the Department
to assist in accomplishment of a departmental function related to the
purposes of this system of records and who have a need to access the
records in order to carry out that function.
2. Transplant centers, physicians and staff, and NMDP participating
organizations, for the purpose of searching for donors or products and/
or facilitating transplants, matching donor blood stem cells with
recipients, monitoring participant outcomes, and monitoring compliance
of member organizations with contractor requirements.
3. Personnel involved in the care of volunteer blood stem cell
donors and management of their participation in the Program.
Disclosures of clinically relevant de-identified information contained
in certain donor records may be made to transplant physicians, patients
or their designated representatives for purposes of facilitating
searches for blood stem cell donors or products and/or facilitation of
unrelated donor transplants.
4. Disclosures may be made by the contractors for the Office of
Patient Advocacy/Single Point of Access, the Bone Marrow Coordinating
Center, the Cord Blood Coordinating Center, the Stem Cell Therapeutic
Outcomes Database, NMDP and CIBMTR participating centers to one another
and their subcontractors (so long as such subcontractors are
contractually bound to comply with the Privacy Act) as well as
participating umbilical cord blood banks to carry out the purposes of
the C.W. Bill Young Cell Transplantation Program.
5. Disclosure may be made to the Department of Justice when: (a)
The agency or any component thereof; or (b) any employee of the agency
in his or her official capacity; (c) any employee of the agency in his
or her individual capacity where agency or the Department of Justice
has agreed to represent the employee; or (d) the United States
Government, is a party to litigation or has an interest in such
litigation, and by careful review, the agency determines that the
records are both relevant and necessary to the litigation and the use
of such records by the Department of Justice is therefore deemed by the
agency to be for a purpose that is compatible with the purpose for
which the agency collected the records.
6. Disclosure may be made to a court or adjudicative body in a
proceeding when: (a) The agency or any component thereof; or (b) any
employee of the agency in his or her official capacity; (c) any
employee of the agency in his or her individual capacity where agency
or the Department of Justice has agreed to represent the employee; or
(d) the United States Government, is a party to litigation or has an
interest in such litigation, and by careful review, the agency
determines that the records are both relevant and necessary to the
litigation and the use of such records is therefore deemed by the
agency to be for a purpose that is compatible with the purpose for
which the agency collected the records.
7. Disclosure may be made to a congressional office from the record
of an individual in response to a verified inquiry from the
congressional office made at the written request of that individual.
8. Disclosure may be made for research purposes. Rarely, with the
appropriate safeguards and consistent with the applicable provisions of
the Privacy Act and the Common Rule (45 CFR Part 46), disclosure for
research purposes may be made when the Department, independently or
through its contractor(s): (a) Has determined that the use or
disclosure does not violate legal or policy limitations under which the
record was provided, collected, or obtained; (b) has determined that a
bona fide research/analysis purpose exists; (c) has required the
recipient to: (1) Establish strict limitations concerning the receipt
and use of patient-identified data; (2) establish reasonable
administrative, technical, and physical safeguards to protect the
confidentiality of the data and to prevent the unauthorized use or
disclosure of the record; (3) remove, destroy, or return the
information that identifies the individual at the earliest time at
which removal or destruction can be accomplished consistent with the
purpose of the research project, unless the recipient has presented
adequate justification of a research or health nature for retaining
such information; and (4) make no further use or disclosure of the
record except as authorized by HHS or its contractor(s) or when
required by law; (d) has determined that other applicable safeguards or
protocols will be followed; and (e) has secured a written statement
attesting to the recipient's understanding of, and willingness to abide
by these provisions.
9. To appropriate Federal agencies and Department contractors that
have a need to know the information for the purpose of assisting the
Department's efforts to respond to a suspected or confirmed breach of
the security or confidentiality of information
[[Page 23872]]
maintained in this system of records, and the information disclosed is
relevant and necessary for that assistance.
Policies and Practices for Storing, Retrieving, Accessing, Retaining,
and Disposing of Records in the System: Storage:
Records are maintained in file folders and in computer data files.
Retrievability:
Patient and donor records may be retrieved by a unique ID assigned
by the system or through the use of other identifying information
(e.g., names, date of birth, Social Security Number, or address).
Safeguards:
1. Authorized users: Access is limited to authorized personnel
responsible for administering the program, including program managers
and program specialists who have responsibilities for implementing the
program and the HRSA Information Systems Security Officer. The
contractor(s) shall maintain current lists of authorized users.
Retrieval of donor or patient records will be limited to authorized
users for search, outcomes data collection and data auditing, or
transplant management purposes.
2. Assign Responsibility for Security: Responsibility is assigned
to a management official knowledgeable of the nature of the information
and processes supported by the C.W. Bill Young Cell Transplantation
Program and in the management, personnel, operational, and technical
controls used to protect it.
3. Perform Risk Assessment: A risk assessment was conducted in
conjunction with the development of the system. The system design
ensures vulnerabilities, risks, and other security concerns are
identified and addressed in the system design and throughout the life
cycle of the project. This is consistent with the HHS Automated
Information Systems Security Program Handbook.
4. Certification and Accreditation: The Program's electronic data
systems are certified under the auspices of HRSA's Office of
Information Technology Certification and Accreditation system.
5. Physical safeguards: All computer equipment and files and hard
copy files are stored in areas where fire and life safety codes (e.g.,
OSHA standards) are strictly enforced. All automated and non-automated
documents are protected on a 24-hour basis. Perimeter security includes
intrusion alarms, key/passcard/combination controls, and receptionist
controlled area. Most hard copy files are maintained in a file room
used solely for purposes of the Program with access limited by
combination lock to authorized users identified above. Computer files
are password protected and are accessible only by use of computers
which are password protected. Servers are password protected and
protected in locked rooms, with access restricted to specific
authorized staff using controls specified in the certification and
accreditation process.
6. Procedural safeguards: A password is required to access computer
files. All users of personal information in connection with the
performance of their jobs protect information from public view and from
unauthorized personnel entering an unsupervised area. All authorized
users sign a nondisclosure statement. All passwords, keys and/or
combinations are changed when a person leaves or no longer has
authorized duties. Access to records is limited to those authorized
personnel trained in accordance with the Privacy Act and automated data
processing (ADP) security procedures. The transmission of records is
protected using secure protocols. Individuals with access to the system
have User IDs and passwords and must be granted access to the system.
External access to the data requires two-factor authentication. The
safeguards described above were established in accordance with NIST
800-53 and OMB Circular A-130 Appendix III.
Retention and Disposal:
HRSA is working with the National Archives and Records
Administration (NARA) to obtain the appropriate retention value of
these records.
System Manager and Address:
Director, Blood Stem Cell Transplantation Program, HRSA, Parklawn
Building, Room 12C-06, 5600 Fishers Lane, Rockville, MD 20857.
Notification Procedure:
Requests must be made to the System Manager.
Requests by mail: Requests for information and/or access to records
received by mail must contain information providing the identity of the
writer, and a reasonable description of the record desired, and whom it
concerns. Written requests must contain the name and address of the
requester, his/her date of birth and his/her signature. Requests must
be notarized to verify the identity of the requester, or the requester
must certify that (s)he is the individual who (s)he claims to be and
that (s)he understands that to knowingly and willfully request or
acquire a record pertaining to another individual under false pretenses
is a criminal offense under the Privacy Act subject to a $5,000 fine
(45 CFR 5b.5(b)(2)(ii)).
Requests in person or by telephone, electronic mail or facsimile
cannot be honored.
Requests in Person:
No requests in person at the system location will be honored.
Requests by Telephone:
Since positive identification of the caller cannot be established,
telephone requests are not honored.
Record Access Procedures:
Record access procedures are the same as notification procedures.
Requesters should also provide a reasonable description of the contents
of the record being sought. A parent or guardian who requests
notification of, or access to, a minor's/incompetent person's record
shall designate a family physician or other health professional (other
than a family member) to whom the record, if any, will be sent. The
parent or guardian must verify relationship to the minor/incompetent
person as well as his/her own identity. Records will be mailed only to
the requester's address that is on file, unless a different address is
demonstrated by official documentation.
Contesting Record Procedures:
To contest a record in the system, contact the official at the
address specified above and reasonably identify the record, specify the
information being contested, and state the corrective action sought and
the reason(s) for requesting the correction, along with supporting
documentation to show how the record is inaccurate, incomplete,
untimely, or irrelevant.
Record Source Categories:
Sources of records include, but are not limited to, patients,
donors, and/or their representatives under the C.W. Bill Young Cell
Transplantation Program and any other sources of information or
documentation submitted by any other person or entity for inclusion in
a request for the purpose of facilitating and monitoring blood stem
cell transplantation (e.g., transplant center healthcare
professionals).
Systems Exempted from Certain Provisions of the Act:
None.
[FR Doc. E9-11946 Filed 5-20-09; 8:45 am]
BILLING CODE 4165-15-P